Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Longeveron Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q4 2024
- Shares held
- 509.8K
- +22.1K (+4.5%) vs. Q4 2024
- Total value
- $790.6K
- −$53.8K (−6.4%) vs. Q4 2024
- New holders
- 2
- 5 more added
- Sold out
- 5
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 144,272 | $223.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 140,731 | $218.1K | 0.00% | +7,126+5.3% | Added |
| UBS Group AG | 55,264 | $85.7K | 0.00% | +54,251+5,355.5% | Added |
| State Street Corp | 45,380 | $70.3K | 0.00% | 00.0% | Unchanged |
| Capital Investment Advisory Services, LLC | 26,525 | $41.1K | 0.00% | 00.0% | Unchanged |
| R Squared Ltd | 24,560 | $38.1K | 0.04% | +15,140+160.7% | Added |
| Commonwealth Equity Services, LLC | 15,955 | $25.0K | 0.00% | +3,500+28.1% | Added |
| Northern Trust Corp | 15,884 | $24.6K | 0.00% | −2,306−12.7% | Reduced |
| Virtu Financial LLC | 14,109 | $22.0K | 0.00% | −16,293−53.6% | Reduced |
| BlackRock, Inc. | 10,016 | $15.5K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 10,000 | $15.5K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,380 | $3.69K | 0.00% | +2,380 | New |
| Advisor Group Holdings, Inc. | 2,000 | $3.10K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,325 | $2.05K | 0.00% | −388−22.7% | Reduced |
| Farther Finance Advisors, LLC | 650 | $975 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 481 | $746 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 114 | $177 | 0.00% | +6+5.6% | Added |
| Aventura Private Wealth, LLC | 78 | $121 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 74 | $115 | 0.00% | −223−75.1% | Reduced |
| SBI Securities Co., Ltd. | 50 | $78 | 0.00% | −7,000−99.3% | Reduced |
| Caitong International Asset Management Co., Ltd | 1 | $2 | 0.00% | +1 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,493−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,681−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,418−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |